"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about CLOZARIL
• Ask Community about CLOZARIL
• CLOZARIL Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

CLOZARIL Safety Questions, CLOZARIL Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CLOZARIL. Our extensive database of CLOZARIL adverse events and CLOZARIL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CLOZARIL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

CLOZARIL Safety Reports

Total CLOZARIL reports: 553.
CLOZARIL FDA safety alerts: 2002 2004 2006 .
Reported deaths: 74    Reported hospitalizations: 220.
Take CLOZARIL Side Effects Survey or Share Your CLOZARIL Story. CLOZARIL Usage.

Showing 1-75 of 553 Next >

Health Professional from UNITED KINGDOM reported CLOZARIL problem on Feb 28, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia, iron deficiency, hyperthyroidism and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: dizziness, dyskinesia, fall, heart rate increased, muscle spasms, muscle twitching. CLOZARIL dosage: 375MG DAILY. During the same period patient was treated with FERROUS SULPHATE, HYOSCINE HYT, CARBIMAZOLE. Patient recovered.

CLOZARIL problem was reported by a Pharmacist from UNITED KINGDOM on Mar 01, 2007. Male patient, 39 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: bundle branch block left, condition aggravated, electrocardiogram qt prolonged. CLOZARIL dosage: unknown. Patient recovered.

Physician from AUSTRALIA reported CLOZARIL problem on Mar 01, 2007. Male patient, 45 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, asthenia, delusion, sedation, weight increased. CLOZARIL dosage: 12.5 MG - 500 MG DAILY. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Health Professional from IRELAND on Mar 09, 2007. Male patient, 38 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, fatigue, weight increased. CLOZARIL dosage: 200 MG, TID. During the same period patient was treated with PAROXETINE. Patient died on 03/04/2007.

Physician from NEW ZEALAND reported CLOZARIL problem on Mar 06, 2007. Male patient, 40 years of age, was diagnosed with arthropod sting, aggression and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: aggression, blood creatine phosphokinase increased, dysstasia, muscle rigidity, neuroleptic malignant syndrome, pneumonia aspiration, pyrexia. CLOZARIL dosage: 700 MG/DAY. During the same period patient was treated with ANTIHISTAMINICS, CHLORPROMAZINE, EPILIM. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Male patient, 42 years of age, was diagnosed with schizophrenia, paranoid type and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: heat stroke, neutrophil count decreased, pneumonia, white blood cell count decreased. CLOZARIL dosage: 900 MG, QD. During the same period patient was treated with CLOZAPINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Mar 07, 2007. Female patient, child 11 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: accidental overdose, hypotension, lethargy, oxygen saturation decreased. CLOZARIL dosage: 100 MG X 2 TABLETS, ONCE/SINGLE. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED KINGDOM on Mar 15, 2007. Male patient, 46 years of age, was diagnosed with schizophrenia, depression, diabetes mellitus and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: cardiotoxicity, diabetes mellitus inadequate control, dyspnoea, electrocardiogram qrs complex prolonged, irritability, no therapeutic response, oedema, weight increased. CLOZARIL dosage: 300 MG/DAY. During the same period patient was treated with PAROXETINE, METFORMIN, GLICLAZIDE, DIAZEPAM. Patient recovered.

Physician from UNITED KINGDOM reported CLOZARIL problem on Mar 15, 2007. Male patient, 46 years of age, was diagnosed with schizophrenia, depression, diabetes mellitus and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: cardiotoxicity, diabetes mellitus inadequate control, dyspnoea, electrocardiogram qrs complex prolonged, irritability, no therapeutic response, oedema, weight increased. CLOZARIL dosage: 300 MG/DAY. During the same period patient was treated with PAROXETINE, METFORMIN, GLICLAZIDE, DIAZEPAM. Patient recovered.

CLOZARIL problem was reported by a Physician from IRELAND on Mar 14, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased. CLOZARIL dosage: unknown. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported CLOZARIL problem on Mar 13, 2007. Male patient was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis chronic. CLOZARIL dosage: 475 MG/DAY. Patient recovered.

CLOZARIL problem was reported by a Health Professional from IRELAND on Mar 13, 2007. Male patient, 33 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, c-reactive protein increased, gait disturbance, overdose, somnolence, suicidal ideation, treatment noncompliance. CLOZARIL dosage: 400 MG/DAY. During the same period patient was treated with SOLIAN, LAMICTAL, PROZAC, EPILIM, ANTABUSE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported CLOZARIL problem on Mar 13, 2007. Male patient, 65 years of age, was diagnosed with accidental exposure and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, balance disorder, confusional state, neutrophil count increased, sedation, somnolence, urinary incontinence, white blood cell count increased. CLOZARIL dosage: 350MG GIVEN IN ERROR. During the same period patient was treated with RISPERIDONE. Patient recovered.

CLOZARIL problem was reported by a Health Professional from IRELAND on Mar 16, 2007. Male patient, 33 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain. CLOZARIL dosage: 600MG/DAY. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported CLOZARIL problem on Mar 15, 2007. Female patient, 47 years of age, weighting 279.9 lb, was diagnosed with schizophrenia, affective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus non-insulin-dependent, overweight. CLOZARIL dosage: 375MG / DAILY. During the same period patient was treated with VENLAFAXINE, KWELLS. Patient recovered.

CLOZARIL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Female patient, 34 years of age, weighting 191.0 lb, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, biopsy liver, blood cholesterol increased, blood triglycerides increased, diabetes mellitus, hepatitis viral, hyperglycaemia. CLOZARIL dosage: unknown. During the same period patient was treated with HALDOL, DEPAKOTE, XANAX, CLONAZEPAM, PAXIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported CLOZARIL problem on Mar 18, 2007. Female patient, 55 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, confusional state, somnolence, vomiting. CLOZARIL dosage: 450MG ONCE/SINGLE. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on July 26, 2006. Female patient, 28 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, leukocytosis, life support, muscular weakness, neuroleptic malignant syndrome, rhabdomyolysis. CLOZARIL dosage: unknown. During the same period patient was treated with ATIVAN, DEPAKOTE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Jan 24, 2006. Male patient, 53 years of age, was diagnosed with psychotic disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: hallucination, auditory. CLOZARIL dosage: unknown. During the same period patient was treated with CLOZAPINE, ESKALITH. Patient recovered.

CLOZARIL problem was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 29 years of age, was diagnosed with psychotic disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: lipids abnormal, pulmonary embolism. CLOZARIL dosage: unknown. Patient died on 09/29/2004.

Health Professional from UNITED STATES reported CLOZARIL problem on Dec 27, 2005. Female patient, 46 years of age, weighting 160.9 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, diabetes mellitus. CLOZARIL dosage: 125MG QAM, 200MG QHS, ORAL. During the same period patient was treated with CLOZAPINE, GLUCOTROL, GLUCOPHAGE, ACTOS, SYNTHROID, BENADRYL. Patient recovered.

CLOZARIL problem was reported by a Pharmacist from UNITED STATES on Nov 14, 2005. Female patient, 60 years of age, was treated with CLOZARIL. CLOZARIL dosage: 400 MG, QHS, ORAL. Patient died.

Physician from UNITED STATES reported CLOZARIL problem on Dec 06, 2005. Female patient, 20 years of age, weighting 242.5 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: myocarditis. CLOZARIL dosage: 200MG QAM, 300MG QHS, ORAL. During the same period patient was treated with DEPAKOTE. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on Jan 27, 2006. Male patient, 52 years of age, weighting 175.9 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: angiogram, chest pain, deep vein thrombosis, oedema peripheral, pain in extremity, pulmonary embolism, thrombolysis, vena cava filter insertion. CLOZARIL dosage: 200MG Q2 AM, 300MG Q3PM, ORAL. During the same period patient was treated with NEXIUM, PAXIL, PROLIXIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CLOZARIL problem on Nov 28, 2005. Male patient, 20 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: eosinophil count increased. CLOZARIL dosage: unknown. Patient recovered.

CLOZARIL problem was reported by a Health Professional from UNITED STATES on Nov 28, 2005. Male patient, 27 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: eosinophil count increased. CLOZARIL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported CLOZARIL problem on Dec 01, 2005. Female patient, 53 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: dyskinesia. CLOZARIL dosage: 100MG AM+200MG PM, ORAL. During the same period patient was treated with ZOLOFT, DEPAKOTE, SEROQUEL, VYTORIN, DILANTIN, COUMADIN, TROPROL. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2006. Male patient, 42 years of age, was diagnosed with psychotic disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, arthralgia, arthritis, blood cholesterol increased, contusion, convulsion, dermatitis, dystonia. CLOZARIL dosage: 300 MG QAM, 200 MG QPHS. During the same period patient was treated with LITHIUM CARBONATE, RISPERDAL, BETAMETHASONE VALERATE W, HYDROXYZINE, FERROMAX, PLENDIL, CLARITIN, VITAMINS AND IRON. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Nov 08, 2005. Male patient, 30 years of age, weighting 209.9 lb, was diagnosed with bipolar disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count decreased. CLOZARIL dosage: 250 MG, QHS, ORAL. During the same period patient was treated with CYMBALTA, DEPAKOTE. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on May 01, 2006. Female patient, 55 years of age, weighting 235.9 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, cardiomegaly, pericardial effusion, pericarditis. CLOZARIL dosage: 100MG BID, 300MG, QHS, ORAL. During the same period patient was treated with ACETAZOLAMIDE, SERTRALINE, CLONAZEPAM, VALSARTAN, GLIMEPIRIDE, GLUCOPHAGE, TIOTROPIUM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Dec 29, 2005. Male patient, 32 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, leukopenia, psychotic disorder. CLOZARIL dosage: unknown. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on Feb 07, 2006. Male patient, 27 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: convulsion. CLOZARIL dosage: 900 MG, QD, ORAL; 450 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLOZARIL problem on Feb 27, 2006. Female patient, weighting 269.8 lb, was diagnosed with schizoaffective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: enuresis, fatigue, palpitations, pollakiuria, stomach discomfort, weight increased. CLOZARIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with CLOZAPINE. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on Feb 09, 2006. Male patient, 24 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, schizophrenia. CLOZARIL dosage: 900 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CLOZARIL problem on Mar 24, 2006. Male patient, 50 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: delusion. CLOZARIL dosage: unknown. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Health Professional from UNITED STATES on Apr 18, 2006. Male patient, 21 years of age, weighting 282.0 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: disease recurrence, mental impairment, neutrophil count increased, schizophrenia, white blood cell count increased. CLOZARIL dosage: 150 MG BID, ORAL. During the same period patient was treated with GEODON, ATIVAN, PREVACID. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on June 06, 2006. Female patient, 40 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: tachycardia. CLOZARIL dosage: 500 MG, QD, ORAL. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on June 07, 2006. Male patient, 26 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, loss of consciousness, supraventricular tachycardia. CLOZARIL dosage: 450 MG, QD, ORAL. During the same period patient was treated with LITHIUM CARBONATE, COGENTIN. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Mar 13, 2006. Male patient, 57 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, leukopenia. CLOZARIL dosage: unknown. Patient recovered.

CLOZARIL problem was reported by a Pharmacist from UNITED STATES on June 26, 2006. Male patient was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: malaise, pneumonia, respiratory tract infection, urinary tract infection. CLOZARIL dosage: 200 MG, BID, ORAL. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on June 14, 2006. Male patient, 19 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, neutrophil count decreased. CLOZARIL dosage: 100 MG, BID. During the same period patient was treated with DEPAKOTE. Patient recovered.

CLOZARIL problem was reported by a Pharmacist from UNITED STATES on Mar 15, 2006. Female patient, 93 years of age, was treated with CLOZARIL. CLOZARIL dosage: unknown. During the same period patient was treated with MORPHINE, TYLENOL. Patient died on 03/13/2006.

Physician from UNITED STATES reported CLOZARIL problem on June 14, 2006. Male patient was diagnosed with schizoaffective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: mobility decreased, pain in extremity, paralysis, rhabdomyolysis. CLOZARIL dosage: 200 MG, QHS, ORAL. During the same period patient was treated with LAMICTAL, ZOLOFT, LORAZEPAM, OXYCONTIN, SYNTHROID, BOTOX. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Health Professional from UNITED STATES on June 15, 2006. Male patient, 58 years of age, was treated with CLOZARIL. CLOZARIL dosage: unknown. Patient died on 05/28/2006.

Pharmacist from UNITED STATES reported CLOZARIL problem on Mar 21, 2006. Male patient, 46 years of age, was treated with CLOZARIL. CLOZARIL dosage: unknown. Patient died.

CLOZARIL problem was reported by a Consumer or non-health professional from UNITED STATES on June 30, 2006. Female patient was diagnosed with paranoia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: constipation, convulsion, weight increased. CLOZARIL dosage: 700 MG, QD, ORAL. Patient recovered.

Pharmacist from UNITED STATES reported CLOZARIL problem on Mar 21, 2006. Female patient was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: dystonia, neuroleptic malignant syndrome. CLOZARIL dosage: 400-425 MG, QD, ORAL; 600 MG, QD, ORAL. During the same period patient was treated with TRILAFON, HALDOL, SEROQUEL. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on Sept 29, 2006. Female patient, 44 years of age, was diagnosed with bipolar disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus non-insulin-dependent, hyperglycaemia. CLOZARIL dosage: 300 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CLOZARIL problem on July 13, 2006. Male patient was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: delusion. CLOZARIL dosage: unknown. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on July 19, 2006. Female patient, 37 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: delusion, feelings of worthlessness, granulocyte count increased, injury, lymphocyte count increased, mean cell haemoglobin increased, overdose, red blood cell count increased. CLOZARIL dosage: 1000 MG, QD, ORAL. During the same period patient was treated with RISPERDAL, DEPAKOTE. Patient died on 07/14/2006.

Physician from UNITED STATES reported CLOZARIL problem on May 15, 2006. Male patient, 68 years of age, was diagnosed with psychotic disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: parkinson's disease. CLOZARIL dosage: 25 MG, Q NOON, 50 MG QPM, ORAL. During the same period patient was treated with SINEMET, ATIVAN, RESTORIL, VICODIN, MORPHINE, METFORMIN, DOXAZOSIN, SINEMET CR. Patient died on 01/23/2006.

CLOZARIL problem was reported by a Health Professional from UNITED STATES on Apr 03, 2006. Female patient, 39 years of age, was diagnosed with psychotic disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: malaise, psychotic disorder. CLOZARIL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Dec 12, 2005. Male patient, 44 years of age, weighting 200.0 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: leukocytosis, thrombocythaemia. CLOZARIL dosage: 300MG QAM, 400MG QHS, ORAL. During the same period patient was treated with DEPAKOTE. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on May 09, 2006. Female patient, 48 years of age, was diagnosed with hallucination and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: delusion, hallucination, poor personal hygiene, psychotic disorder. CLOZARIL dosage: unknown. During the same period patient was treated with GEODON, ZYPREXA. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Jan 31, 2006. Male patient, 42 years of age, was treated with CLOZARIL. CLOZARIL dosage: unknown. Patient died on 11/01/2005.

CLOZARIL problem was reported by a Physician from UNITED STATES on May 03, 2006. Male patient, 53 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, chest discomfort, gait disturbance, malaise. CLOZARIL dosage: 100 MG, TID, ORAL. During the same period patient was treated with PROMETHAZINE, AMLODIPINE, CAPTOPRIL, PREDNISONE, SINGULAIR, CHLORPROMAZINE, BENZTROPINE MESYLATE, TRAZODONE. Patient was hospitalized. Patient died on 04/12/2006.

Health Professional from UNITED STATES reported CLOZARIL problem on Apr 24, 2006. Male patient, child 10 years of age, was diagnosed with bipolar disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, disease progression, sinusitis. CLOZARIL dosage: 400 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on Dec 20, 2005. Female patient, 84 years of age, was diagnosed with parkinson's disease and was treated with CLOZARIL. CLOZARIL dosage: 25 MG, QHS, ORAL. Patient died.

Physician from UNITED STATES reported CLOZARIL problem on May 16, 2006. Male patient, 45 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: platelet count increased. CLOZARIL dosage: unknown. During the same period patient was treated with ABILIFY. Patient recovered.

CLOZARIL problem was reported by a Health Professional from UNITED STATES on Dec 20, 2005. Male patient, 43 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: extrapyramidal disorder, psychomotor hyperactivity, tremor, white blood cell count decreased. CLOZARIL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported CLOZARIL problem on Apr 29, 2006. Male patient, 27 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: hallucination, auditory, suicidal ideation. CLOZARIL dosage: 500 MG, QD, ORAL. Patient recovered.

CLOZARIL problem was reported by a Pharmacist from UNITED STATES on June 20, 2006. Female patient, 68 years of age, was treated with CLOZARIL. CLOZARIL dosage: 225 MG, QD, ORAL. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported CLOZARIL problem on Jan 10, 2006. Female patient, 50 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: leukocytosis, neutrophil count abnormal. CLOZARIL dosage: unknown. During the same period patient was treated with CLOZAPINE. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on July 26, 2006. Female patient, 19 years of age, was diagnosed with schizophrenia, insomnia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. CLOZARIL dosage: 400 MG, QD, ORAL. During the same period patient was treated with ZOLOFT, TRAZODONE, SEROQUEL, COGENTIN, METFORMIN, LIPITOR, PRILOSEC, COLACE. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Sept 22, 2006. Male patient, 37 years of age, weighting 220.0 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: hypertriglyceridaemia. CLOZARIL dosage: unknown. During the same period patient was treated with CLONAZEPAM, ARICEPT. Patient recovered.

CLOZARIL problem was reported by a Health Professional from UNITED STATES on Feb 14, 2006. Male patient, 43 years of age, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: catatonia, pneumonia, white blood cell count increased. CLOZARIL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CLOZARIL problem on July 28, 2006. Male patient, 55 years of age, was treated with CLOZARIL. CLOZARIL dosage: unknown. Patient died on 07/27/2006.

CLOZARIL problem was reported by a Physician from UNITED STATES on Feb 03, 2006. Female patient, 56 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood triglycerides increased, constipation, diabetes mellitus, glycosylated haemoglobin increased, weight increased. CLOZARIL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported CLOZARIL problem on Sept 12, 2006. Male patient, 53 years of age, weighting 177.9 lb, was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: akathisia, anger, blood cholesterol increased, blood triglycerides increased, confusional state, fatigue, feeling abnormal, headache. CLOZARIL dosage: unknown. During the same period patient was treated with TOPAMAX, RISPERDAL, ZOLOFT, DEPAKOTE, WELLBUTRIN, FIBERCON, COLACE. Patient died on 08/04/2006.

CLOZARIL problem was reported by a Physician from UNITED STATES on Feb 09, 2006. Male patient, 57 years of age, weighting 175.9 lb, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: asthenia, blood creatine phosphokinase increased, blood creatinine increased, blood glucose increased, blood potassium increased, blood urea increased, convulsion, hyperhidrosis, mental status changes. CLOZARIL dosage: 300MG QAM, 400MG QPM, ORAL. During the same period patient was treated with LEVAQUIN, FLAGYL, ROCEPHIN, PROTONIX, PROZAC. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Aug 10, 2006. Male patient, 52 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, confusional state, musculoskeletal stiffness, neuroleptic malignant syndrome, pain. CLOZARIL dosage: 100 MG, BID, ORAL. During the same period patient was treated with ZOLOFT, ASPIRIN, DITROPAN, MIRALAX. Patient was hospitalized. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on Aug 17, 2006. Male patient was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: dizziness, mental status changes. CLOZARIL dosage: 300 MG, QD. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Aug 17, 2006. Female patient was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, paranoia, psychotic disorder. CLOZARIL dosage: 500 MG, QD, ORAL. Patient recovered.

CLOZARIL problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Female patient, 45 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, hallucination, auditory, neutrophil count decreased, pyrexia, schizophrenia, disorganised type, sedation, white blood cell count decreased. CLOZARIL dosage: 300 MG, QD, UNK. During the same period patient was treated with LITHIUM CARBONATE, ATIVAN, ANAFRANIL, SEROQUEL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CLOZARIL problem on Aug 24, 2006. Female patient, 19 years of age, was diagnosed with schizoaffective disorder and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: white blood cell count decreased. CLOZARIL dosage: 300 MG, Q 12H,. Patient was hospitalized. Patient recovered.

Showing 1-75 of 553 Next >

Ask Our Patient Community about CLOZARIL
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin